Pages that link to "Q51083991"

The following pages link to The cannabinoid agonist HU 210 modifies rat behavioural responses to novelty and stress (Q51083991):

Displaying 22 items.

• The endocannabinoid system as an emerging target of pharmacotherapy (Q24648473) (← links)
• CB1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction (Q30918735) (← links)
• Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats. (Q34192001) (← links)
• The endocannabinoid nervous system: unique opportunities for therapeutic intervention (Q34305854) (← links)
• Hu 210: a potent tool for investigations of the cannabinoid system. (Q34320139) (← links)
• Alteration of imprinted Dlk1-Dio3 miRNA cluster expression in the entorhinal cortex induced by maternal immune activation and adolescent cannabinoid exposure (Q34370550) (← links)
• Cannabis and anxiety: a critical review of the evidence (Q34998397) (← links)
• Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2. (Q35626928) (← links)
• Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission (Q35839753) (← links)
• Endocannabinoid system and synaptic plasticity: implications for emotional responses (Q36887168) (← links)
• Antiaversive effects of cannabinoids: is the periaqueductal gray involved? (Q41351855) (← links)
• The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. (Q42686860) (← links)
• Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain (Q43235028) (← links)
• Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters (Q43744072) (← links)
• Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats (Q44288279) (← links)
• Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala (Q44998040) (← links)
• Effects of delta9-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable stress. (Q46029912) (← links)
• Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats (Q46784380) (← links)
• Effects of the cannabinoid receptor agonist, HU 210, on ingestive behaviour and body weight of rats (Q47243602) (← links)
• Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA. (Q48020201) (← links)
• Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure (Q48131076) (← links)
• Inhibitory effects of the cannabinoid agonist HU 210 on rat sexual behaviour (Q74063376) (← links)